McKesson Co. (NYSE:MCK) – Equities research analysts at Leerink Swann cut their Q1 2016 EPS estimates for McKesson in a note issued to investors on Thursday, according to Zacks Investment Research. Leerink Swann analyst D. Larsen now expects that the brokerage will post earnings of $3.17 per share for the quarter, down from their prior estimate of $3.33. Leerink Swann has a “Outperform” rating and a $200.00 price target on the stock. The consensus estimate for McKesson’s Q1 2016 earnings is $3.15 per share. Leerink Swann also issued estimates for McKesson’s Q2 2016 earnings at $3.20 EPS and Q3 2016 earnings at $3.40 EPS.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, January 27th. The company reported $3.18 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.13 by $0.05. The company had revenue of $47.90 billion for the quarter, compared to analyst estimates of $48.97 billion. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the firm earned $2.89 EPS.

MCK has been the subject of several other research reports. Deutsche Bank reissued a “buy” rating and issued a $199.00 price target (down previously from $200.00) on shares of McKesson in a research note on Wednesday, January 27th. Goldman Sachs decreased their target price on McKesson from $214.00 to $191.00 in a research note on Tuesday, January 12th. RBC Capital decreased their target price on McKesson from $231.00 to $210.00 in a research note on Friday, October 30th. Barclays reaffirmed an “overweight” rating and set a $211.00 target price (down previously from $220.00) on shares of McKesson in a research note on Friday, January 15th. Finally, Mizuho reaffirmed a “buy” rating and set a $210.00 target price (down previously from $275.00) on shares of McKesson in a research note on Tuesday, October 27th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $214.62.

McKesson (NYSE:MCK) opened at 160.98 on Monday. The firm’s 50 day moving average price is $182.09 and its 200 day moving average price is $195.04. The firm has a market cap of $36.80 billion and a price-to-earnings ratio of 19.26. McKesson has a 52-week low of $152.22 and a 52-week high of $243.61.

Several hedge funds and institutional investors recently bought and sold shares of the stock. Stock Yards Bank & Trust Company bought a new position in McKesson during the fourth quarter worth $5,344,000. Creative Planning increased its stake in shares of McKesson by 24.0% in the fourth quarter. Creative Planning now owns 21,458 shares of the company’s stock worth $4,232,000 after buying an additional 4,151 shares during the last quarter. Factory Mutual Insurance Company increased its stake in shares of McKesson by 21.9% in the fourth quarter. Factory Mutual Insurance Company now owns 222,900 shares of the company’s stock worth $43,963,000 after buying an additional 40,000 shares during the last quarter. Capital Investment Advisors increased its stake in shares of McKesson by 49.9% in the fourth quarter. Capital Investment Advisors now owns 3,964 shares of the company’s stock worth $782,000 after buying an additional 1,319 shares during the last quarter. Finally, CUE Financial Group increased its stake in shares of McKesson by 11.2% in the fourth quarter. CUE Financial Group now owns 8,481 shares of the company’s stock worth $1,673,000 after buying an additional 855 shares during the last quarter.

In other news, CEO John H. Hammergren sold 101,833 shares of the firm’s stock in a transaction that occurred on Monday, January 4th. The stock was sold at an average price of $194.11, for a total value of $19,766,803.63. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 1st. Stockholders of record on Tuesday, March 1st will be issued a $0.28 dividend. The ex-dividend date is Friday, February 26th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.70%.

McKesson Corporation (NYSE:MCK) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

12 Month Chart for NYSE:MCK

Get a free copy of the Zacks research report on McKesson (MCK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Frustrated with your broker? Are you tired of paying high fees? Do you feel like you are getting ripped off by your stock broker? It's time for a change. Find out which brokerage is best for your personal trading style at the InvestorPlace Broker Center. Compare brokers at a glance in the InvestorPlace Broker Center (Click Here).

Receive News & Ratings for McKesson Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Co. and related companies with MarketBeat.com's FREE daily email newsletter.